المؤلفون: Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Kydd AR; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Simon N; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chandran E; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Rastogi S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Sato N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cao L; Molecular Targets Core, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Banday AR; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Boudjadi S; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Merino MJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Toubaji A; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Akbulut D; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Redd B; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD., Bagheri H; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gurram S; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Agarwal PK; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Valera V; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Sharon E; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Parnes HL; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gulley JL; Center for Onco-Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Saraiya B; Genitourinary Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA., Quinn D; Division of Cancer Medicine and Blood Diseases, Department of Medicine, Genitourinary Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA., Stein MN; Genitourinary Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY., Lara PN; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 02, pp. JCO2302233. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

المؤلفون: Miranda TA; Department of Medical Oncology, Hospital Sírio-Libanês, Brasília, Brazil., Girardi DM; Department of Medical Oncology, Hospital Sírio-Libanês, Brasília, Brazil., Pereira AAL; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.

المصدر: Chinese clinical oncology [Chin Clin Oncol] 2024 Jun; Vol. 13 (3), pp. 44. Date of Electronic Publication: 2024 Jan 19.

نوع المنشور: Editorial; Journal Article

بيانات الدورية: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2304-3873 (Electronic) Linking ISSN: 23043865 NLM ISO Abbreviation: Chin Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/drug therapy , Nivolumab*/pharmacology , Nivolumab*/therapeutic use , Pyridines*/pharmacology , Pyridines*/therapeutic use , Anilides*/pharmacology , Anilides*/therapeutic use , Ipilimumab*/therapeutic use , Ipilimumab*/pharmacology, Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology

المؤلفون: Girardi DM; Hospital Sírio-Libanes, SGAS 613/614 Conjunto E Lote 95-Asa Sul, Brasília 70200-730, Brazil.; Hospital de Base do Distrito Federal, SMHS-Área Especial, Q. 101-Asa Sul, Brasília 70330-150, Brazil., Sousa LP; Escola Superior de Ciências em Saúde, SMHN Conjunto A Bloco 01 Edifício Fepecs-Asa Norte, Brasília 70710-907, Brazil., Miranda TA; Escola Superior de Ciências em Saúde, SMHN Conjunto A Bloco 01 Edifício Fepecs-Asa Norte, Brasília 70710-907, Brazil., Haum FNC; Escola Superior de Ciências em Saúde, SMHN Conjunto A Bloco 01 Edifício Fepecs-Asa Norte, Brasília 70710-907, Brazil., Pereira GCB; Hospital Sírio-Libanes, SGAS 613/614 Conjunto E Lote 95-Asa Sul, Brasília 70200-730, Brazil.; Hospital de Base do Distrito Federal, SMHS-Área Especial, Q. 101-Asa Sul, Brasília 70330-150, Brazil., Pereira AAL; Hospital Sírio-Libanes, SGAS 613/614 Conjunto E Lote 95-Asa Sul, Brasília 70200-730, Brazil.; Hospital de Base do Distrito Federal, SMHS-Área Especial, Q. 101-Asa Sul, Brasília 70330-150, Brazil.

المصدر: Cancers [Cancers (Basel)] 2023 Mar 09; Vol. 15 (6). Date of Electronic Publication: 2023 Mar 09.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Nadal R; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes, National Institutes of Health, Bethesda, MD., Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Hahn NM; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD., Bellmunt J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: jbellmun@bidmc.harvard.edu.

المصدر: Urologic oncology [Urol Oncol] 2023 Jan; Vol. 41 (1), pp. 27-34. Date of Electronic Publication: 2020 Oct 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Carcinoma, Transitional Cell*/pathology, Humans ; Cisplatin/therapeutic use ; BCG Vaccine/therapeutic use ; Immune Checkpoint Inhibitors ; Neoplasm Recurrence, Local/surgery ; Cystectomy/methods ; Neoadjuvant Therapy ; Immunotherapy ; Neoplasm Invasiveness

المؤلفون: Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ghatalia P; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Singh P; Department of Medicine, Mayo Clinic, Phoenix, AZ., Iyer G; Department of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Sridhar SS; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON., Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: andrea.apolo@nih.gov.

المصدر: Urologic oncology [Urol Oncol] 2023 Jan; Vol. 41 (1), pp. 39-47. Date of Electronic Publication: 2020 Nov 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology, Humans ; Urinary Bladder/surgery ; Urinary Bladder/pathology ; Cisplatin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cystectomy ; Neoadjuvant Therapy

المؤلفون: Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, Ohio., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lara P; University of California Davis Comprehensive Cancer Center, Sacramento, California., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California., Saraiya B; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Cordes L; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ortiz OS; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Cadena J; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Diaz C; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Bagheri H; Clinical Image Processing Service, Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland., Redd B; Clinical Image Processing Service, Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Chan KS; Samuel Oschin Cancer Center, Cedars Sinai Medical Center, Los Angeles, California., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lee S; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Yu Y; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Gurram S; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Valera V; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Merino M; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Toubaji A; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Sharon E; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Parnes HL; Division of Cancer Prevention, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ning YM; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Cao L; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Trepel JB; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 01; Vol. 28 (7), pp. 1353-1362.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/drug therapy , Urinary Bladder Neoplasms*/drug therapy, Anilides ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Immune Checkpoint Inhibitors ; Nivolumab ; Pyridines

المؤلفون: Girardi DM; Hospital Sírio-Libanes, SGAS 613/614 Conjunto E Lote 95-Asa Sul, Brasília 70200-730, Brazil.; Hospital de Base do Distrito Federal, SMHS-Área Especial, Q. 101-Asa Sul, Brasília 70330-150, Brazil., Pacífico JPM; Escola Superior de Ciências em Saúde, SMHN Conjunto A Bloco 01 Edifício Fepecs-Asa Norte, Brasília 70710-907, Brazil., Guedes de Amorim FPL; Escola Superior de Ciências em Saúde, SMHN Conjunto A Bloco 01 Edifício Fepecs-Asa Norte, Brasília 70710-907, Brazil., Dos Santos Fernandes G; Hospital Sírio-Libanes, SGAS 613/614 Conjunto E Lote 95-Asa Sul, Brasília 70200-730, Brazil., Teixeira MC; Hospital de Base do Distrito Federal, SMHS-Área Especial, Q. 101-Asa Sul, Brasília 70330-150, Brazil.; Hospital DF Star, SGAS I SGAS 914-Asa Sul, Brasília 70390-140, Brazil., Pereira AAL; Hospital Sírio-Libanes, SGAS 613/614 Conjunto E Lote 95-Asa Sul, Brasília 70200-730, Brazil.; Hospital de Base do Distrito Federal, SMHS-Área Especial, Q. 101-Asa Sul, Brasília 70330-150, Brazil.

المصدر: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2020 Dec 31; Vol. 14 (1). Date of Electronic Publication: 2020 Dec 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Sierra Ortiz O; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cadena J; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Diaz C; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mallek M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Davarpanah NN; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Trepel JB; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Merino MJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Bagheri MH; Clinical Image Processing Service, Clinical Center, National Institutes of Health, Bethesda, MD., Monk P; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Agarwal PK; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Valera V; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Jones J; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Rockville, MD., Ning YM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Parnes HL; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD., Dahut WL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lara PN Jr; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Saraiya B; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA., Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 01; Vol. 38 (31), pp. 3672-3684. Date of Electronic Publication: 2020 Sep 11.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Transitional Cell/*drug therapy , Urogenital Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Anilides/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; B7-H1 Antigen/metabolism ; Carcinoma, Transitional Cell/secondary ; Colitis/chemically induced ; Diarrhea/chemically induced ; Epithelial Cell Adhesion Molecule/metabolism ; Fatigue/chemically induced ; Female ; Hepatitis/etiology ; Humans ; Hypertension/chemically induced ; Ipilimumab/administration & dosage ; Male ; Middle Aged ; Neoplastic Cells, Circulating/metabolism ; Nivolumab/administration & dosage ; Progression-Free Survival ; Proto-Oncogene Proteins c-met/metabolism ; Pyridines/administration & dosage ; Receptors, CXCR4/metabolism ; Response Evaluation Criteria in Solid Tumors ; Survival Rate ; Young Adult

المؤلفون: Girardi DM; Department of Oncology, Hospital Sírio-Libanes, SGAS 613-conjunto E lote 95-Asa Sul, Brasília, DF, 70200-001, Brazil. danielmgirardi@gmail.com., Faria LDBB; Department of Oncology, Hospital Sírio-Libanes, SGAS 613-conjunto E lote 95-Asa Sul, Brasília, DF, 70200-001, Brazil., Teixeira MC; Department of Oncology, Hospital Sírio-Libanes, SGAS 613-conjunto E lote 95-Asa Sul, Brasília, DF, 70200-001, Brazil., Costa FP; Department of Oncology, Hospital Sírio-Libanes, SGAS 613-conjunto E lote 95-Asa Sul, Brasília, DF, 70200-001, Brazil., Hoff PMG; Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Fernandes GS; Department of Oncology, Hospital Sírio-Libanes, SGAS 613-conjunto E lote 95-Asa Sul, Brasília, DF, 70200-001, Brazil.

المصدر: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2019 Dec; Vol. 50 (4), pp. 860-866.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Science+Business Media Country of Publication: United States NLM ID: 101479627 Publication Model: Print Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*pharmacology , Deoxycytidine/*analogs & derivatives , Pancreatic Neoplasms/*drug therapy, Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Brazil/epidemiology ; Deoxycytidine/pharmacology ; Deoxycytidine/therapeutic use ; Disease Progression ; Drug Resistance, Neoplasm ; Electronic Health Records/statistics & numerical data ; Female ; Fluorouracil/pharmacology ; Fluorouracil/therapeutic use ; Follow-Up Studies ; Humans ; Irinotecan/pharmacology ; Irinotecan/therapeutic use ; Kaplan-Meier Estimate ; Leucovorin/pharmacology ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Oxaliplatin/pharmacology ; Oxaliplatin/therapeutic use ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Progression-Free Survival ; Quality of Life ; Retrospective Studies ; Gemcitabine

المؤلفون: Fernandes GS; Department of Oncology, Hospital Sírio Libanês, SGAS 613, conjunto E lote 95, Asa Sul, Brasília, DF, 70200-001, Brazil. Gustavo.hemato@gmail.com., Girardi DM; Department of Oncology, Hospital Sírio Libanês, SGAS 613, conjunto E lote 95, Asa Sul, Brasília, DF, 70200-001, Brazil., Bernardes JPG; Department of Radiology, Hospital Sírio Libanês, São Paulo, Brazil., Fonseca FP; Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Fregnani ER; Oral Medicine Department, Sírio-Libanês Hospital, São Paulo, Brazil.

المصدر: BMC cancer [BMC Cancer] 2018 Sep 12; Vol. 18 (1), pp. 887. Date of Electronic Publication: 2018 Sep 12.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Ameloblastoma/*drug therapy , Ameloblastoma/*genetics , Jaw Neoplasms/*drug therapy , Jaw Neoplasms/*genetics , Protein Kinase Inhibitors/*therapeutic use , Proto-Oncogene Proteins B-raf/*genetics, Adult ; Alleles ; Ameloblastoma/diagnosis ; Amino Acid Substitution ; Biomarkers, Tumor ; Biopsy ; Female ; Humans ; Immunohistochemistry ; Jaw Neoplasms/diagnosis ; Magnetic Resonance Imaging ; Molecular Targeted Therapy ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Treatment Outcome